CME Group (CME) to Release Earnings on Wednesday

CME Group (NASDAQ:CME) is expected to issue its Q4 2025 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $2.69 per share and revenue of $1.6351 billion for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:30 AM ET.

CME Group Stock Up 0.6%

Shares of CME Group stock opened at $290.77 on Tuesday. CME Group has a 1-year low of $238.12 and a 1-year high of $293.78. The company has a market capitalization of $104.85 billion, a PE ratio of 28.18, a P/E/G ratio of 3.26 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The business has a 50-day moving average of $275.56 and a 200-day moving average of $272.39.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio (DPR) is 48.45%.

Insider Activity

In other CME Group news, Director William R. Shepard bought 251 shares of the business’s stock in a transaction on Tuesday, December 30th. The shares were purchased at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the acquisition, the director directly owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Empowered Funds LLC lifted its stake in CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after buying an additional 1,037 shares during the last quarter. Marshall Wace LLP increased its holdings in shares of CME Group by 103.1% in the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after acquiring an additional 121,707 shares during the period. Federated Hermes Inc. lifted its position in CME Group by 1,325.2% in the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after purchasing an additional 21,918 shares during the last quarter. Nebula Research & Development LLC acquired a new position in CME Group during the 2nd quarter valued at about $992,000. Finally, The Manufacturers Life Insurance Company boosted its stake in CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after purchasing an additional 7,397 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Morgan Stanley cut their target price on CME Group from $320.00 to $319.00 and set an “overweight” rating on the stock in a research report on Thursday, January 15th. TD Cowen upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a report on Thursday, January 22nd. Finally, Bank of America upped their target price on shares of CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average target price of $292.18.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.